KLOW 80 mg
Educational guide for reconstituting the VERIX KLOW 80 mg research blend (KPV 10 mg + BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg) and mapping total-blend daily draws to U-100 units. Research use only.
Vial
80 mg
Your BAC water
3 mL
Concentration
26.67 mg/mL
Per unit
~266.7 mcg
Frequency
Once daily subcutaneous (multi-week course; some protocols 5 days on / 2 off)
Route
Subcutaneous
Blend composition
Fixed ratio in every draw. Per-draw amounts follow your calculator dose (1.33 mg total blend).
| Component | In vial | Share | Per draw |
|---|---|---|---|
| GHK-Cu | 50 mg | 62.5% | 831 mcg |
| KPV | 10 mg | 12.5% | 166 mcg |
| BPC-157 | 10 mg | 12.5% | 166 mcg |
| TB-500 | 10 mg | 12.5% | 166 mcg |
Total listed mass 80 mg. Step 2 of the calculator is total blend — not one peptide alone.
Live reconstitution calculator
Defaults match this guide (80 mg + 3 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
Quick-select common research doses (includes 2.5 / 7.5 for dual-agonist ladders) or type any mg / mcg value.
Quick select (mg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
5.0 units
Volume
0.050 mL
Doses per vial
60.2
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 5.0 u
Fill one 30-unit U-100 syringe to about 5.0 units (0.050 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (3 mL BAC → 26.67 mg/mL · 266.7 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Community tables often use ~1.3–4 mg total blend per injection (≈5–15 units at 3 mL recon), daily for 4–8 weeks, then time off.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Days 1–14 (intro) | 1.33 mg1,330 mcg | 5.0 u | 0.05 mL≈5 units @ 3 mL recon · GHK-Cu ~0.83 mg · KPV/BPC/TB ~167 mcg each |
| Days 15–42 (standard) | 2.67 mg2,670 mcg | 10.0 u | 0.10 mL≈10 units @ 3 mL · GHK-Cu ~1.67 mg · KPV/BPC/TB ~333 mcg each |
| Days 43–56 (optional taper frequency) | 2.67 mg2,670 mcg | 10.0 u | 0.10 mLSame draw size; many write-ups drop frequency — count injection days only |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Loading · 4 mg daily × 28 days | 4 mg4,000 mcg | 15.0 u | 0.15 mL≈15 units @ 3 mL · or 10 units if you switch Step 1 to 2 mL BAC |
| Higher daily · 4 mg × 42 days | 4 mg4,000 mcg | 15.0 u | 0.15 mLAggressive research-community discussion range — watch copper exposure from GHK-Cu share |
Supplies planner
Using the guide’s phase ladder (1.33 mg → 2.67 mg → 2.67 mg per injection (phase ladder)) over a 52-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
3 mL · 26.67 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
52-day course
KLOW 80 mg vials
2 vials
~120.08 mg mg total peptide over this 52-day course at 1.33 mg → 2.67 mg → 2.67 mg per injection (phase ladder). Each vial holds 80 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
3 mL BAC per vial × 2 vials = 6.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
52+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~108 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 80 mg KLOW vial and bacteriostatic water to reach room temperature.
- Draw 3.0 mL bacteriostatic water (default). 2.0 mL is also common if you want denser 10-unit draws.
- Inject BAC slowly down the inner wall — multi-peptide cakes foam easily if blasted.
- Gently swirl or roll until fully dissolved and the solution looks uniform (GHK-Cu can tinge the liquid blue-green). Do not shake hard.
- Label with recon date, BAC volume, and “80 mg total blend / KLOW”. Refrigerate at 2–8 °C (35–46 °F), protected from light.
- Prefer finishing a reconstituted multi-peptide vial within ~28 days with sterile technique.
Storage
Lyophilized
Store dry powder cold and dark (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw. Multi-peptide blends are typically used within ~4 weeks after recon.
- ·Copper-peptide solutions can look blue-green — that can be normal for GHK-Cu; discard if cloudy, particulates, or odd odor appear.
- ·Document recon date and BAC mL on the label.
- ·Protect from light during storage.
Protocol notes
- ·Doses in the calculator and tables are TOTAL BLEND milligrams — not a single peptide. The 50/10/10/10 ratio stays fixed in every draw.
- ·Typical framing: daily subcutaneous injections for 4–8 weeks, then time off.
- ·Research use only. Not medical advice.
Research context & considerations
KLOW (VERIX naming) is a four-peptide research blend: KPV, BPC-157, GHK-Cu, and TB-500 / thymosin β4 fragment. Evidence is component-wise; there are no large RCTs of this exact tetrad.
- ·Injection-site reactions are the most common practical issue.
- ·GHK-Cu contributes meaningful copper — extra caution with Wilson disease / copper disorders.
- ·Not FDA-approved. Not for human consumption as a drug substitute.
- ·Pregnancy and breastfeeding are outside research-hobby scope.
Catalog match
KLOW(KPV 10mg+BPC 157 10mg+GHK-CU50mg+TB500 10mg)
80mg x 10 vials · from $135